Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Pre-liver Transplant Patients
NCT00697554Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2000
- Primary completion
- May 2002
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 3 trial of hepatitis b vaccine recombinant in hepatitis B (HBV), sponsored by GSK. Started Jan 2000; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00697554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00697554.